✦ LIBER ✦

Treatment of disseminated ocular melanoma with sequential fotemustine, interferon α, and interleukin 2

✍ Scribed by Becker, J C; Terheyden, P; Kämpgen, E; Wagner, S; Neumann, C; Schadendorf, D; Steinmann, A; Wittenberg, G; Lieb, W; Bröcker, E-B

Book ID: 109997355
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 126 KB
Volume: 87
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6600521

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequential treatment of patients with ad

Sequential treatment of patients with advanced renal cell carcinoma with autologous tumor vaccine and subcutaneous administration of recombinant interleukin-2 and interferon α2b

✍ S. Pomer; R. Thiele; V. Daniel; R. Weimer; H. Löhrke; V. Schirrmacher; G. Staehl 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 820 KB

Thirty patients with advanced renal cell carcinoma (RCC), 23 of whom had distant metastases in at least one organ, were entered after nephrectomy into a protocol involving vaccination with Newcastle disease virus (NDV)-modified autologous tumour material, with a subsequent induction week and repetit

Eradication of mouse melanoma by combine

Eradication of mouse melanoma by combined treatment with recombinant human interleukin 2 and recombinant murine interferon-gamma

✍ Selma Silagi; Regina Dutkowski; Annette Schaefer 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 904 KB

Successful immunotherapy of early S.C. or i.p. (816) melanoma in syngeneic C57BL/6 (86) mice was achieved with S.C. peri-lesional injections (for S.C. tumors) o r i.p. injections (for i.p. tumors) of recombinant human interleukin 2 (rlL-2) and recombinant murine interferon-gamma (rlFN-7). Over a 28d

Final report of a phase II study of inte

Final report of a phase II study of interleukin 2 and interferon α in patients with metastatic melanoma

✍ Kruit, WHJ; Goey, SH; Calabresi, F; Lindemann, A; Stahel, RA; Poliwoda, H; Oster 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 507 KB

Dacarbazine (DTIC) and human recombinant

Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma

✍ Mulder, NH; Willemse, PHB; Schraffordt Koops, H; de Vries, EGE; Sleijfer, DTh 📂 Article 📅 1990 🏛 Nature Publishing Group 🌐 English ⚖ 334 KB

Production of tumor necrosis factor α an

Production of tumor necrosis factor α and interferon γ in interleukin-2-treated melanoma patients: Correlation with clinical toxicity

✍ James S. Economou; Mary Hoban; Jeffrey D. Lee; Richard Essner; Stephen Swisher; 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 548 KB

Induction of tyrosinase-reactive T cells

Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha ± interleukin-2 in patients with metastatic melanoma

✍ Alexander Schmittel; Ulrich Keilholz; Regina Max; Eckhard Thiel; Carmen Scheiben 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 92 KB 👁 2 views

We have shown the presence of tyrosinase-reactive T cells in the peripheral blood of melanoma patients, who had been in remission after treatment with IL-2-containing regimens. In this consecutive study, we analyzed the T-cell response to various peptides derived from tyrosinase in serial blood samp